The role of optic nerve lamina region stem cells in age-related optic nerve disease
The role of optic nerve lamina region stem cells in age-related optic nerve disease
批准号:
10443202
负责人:
STEVEN L BERNSTEIN
金额:
$42.73万
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
未结题
起止时间:
2022-09-30 至 2027-06-30
关键词:
AcuteAgeAgingAnteriorAnterior Ischemic Optic NeuropathyApoptosisAstrocytesAxonBiologicalBlindnessBlood VesselsCell Culture TechniquesCell DeathCell SurvivalCellsCellular StressCessation of lifeCouplingDefectDiseaseDisease ResistanceDissectionDistalEyeGanciclovirGlaucomaGrowthGrowth FactorHealthHumanIndividualMediatingMembraneMicroRNAsModelingMolecularMusNatural regenerationNeurosphereNon-Rodent ModelNuclear Pore ComplexOptic DiskOptic NervePatientsPhagocytesPhysiologic Intraocular PressurePredispositionPrevalencePrimary Open Angle GlaucomaProcessPropertyProteinsRattusResistanceRetinaRetinal Ganglion CellsRodentRodent ModelRoleStressSupporting CellTechniquesThinkingThymidine KinaseTransgenic MiceTransgenic ModelVesicleVisionage relatedagedaxonopathybiomarker paneldeep sequencingeffective therapyenhancing factorexosomeextracellular vesiclesimprovedimproved outcomein vivoinjury recoveryinnovationmyelinationnanovesiclenerve stem cellnestin proteinneuroprotectionnonhuman primateoptic nerve disorderpostnatalstem cell biomarkersstem cells
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The most common age-associated optic nerve (ON)-related causes of vision loss are non-arteritic
anterior ischemic optic neuropathy (NAION) and primary open-angle glaucoma (POAG). Optic nerve head
(ONH) defects contribute to NAION and POAG susceptibility, but the mechanisms responsible for this are
incompletely understood, contributing to a lack of effective treatments. My lab recently discovered that the optic
nerve-laminar region (ONLR) within the ONH, contains a CNS neural stem cell/neural progenitor cell
(NSC/NPC) niche which is depleted during aging. Increased CNS-NPC activity has been shown to improve
baseline CNS activity in aged mice, and NPC depletion impedes CNS recovery following injury.
NPCs secrete extracellular vesicles (‘exosomes’) that mediate many of the positive effects of CNS-
NPCs. We find that administering human ONLR-NPC-secreted exosomes enhance RGC survival ex vivo and
stimulates RGC-neuritigenesis. Depleting ONLR-NPCs in a mouse transgenic model increases markers of
RGC stress, using an RGC stress-marker panel. I hypothesize that ONLR-NPCs support RGC survival, and
they do this in part by vesicle secretion. I predict their loss increases RGC stress and susceptibility to death
after axonal ischemic stress, and supplementing RGCs with ONLR-NPC-extracellular vesicles will enhance
RGC survival after axonal stress. We will prove this with two rodent species and two specific aims.
Specific aim 1: Demonstrate that mouse ONLR-NPC loss results in RGC stress and increases
RGC death in ON disease. We will couple a mouse transgenic model enabling selective ONLR-NPC
depletion, the rodent model of NAION rNAION model, and stereology (statistically robust cell quantification).
We will utilize molecular and cell biological techniques for identifying RGC cell stress and apoptosis. We will
then: A) Determine whether acute ONLR-NPC depletion results in RGC stress, via stress marker analysis and
B) Whether this depletion enhances RGC death after rNAION-induced RGC ischemic axonal stress. I predict
increased RGC stress, demonstrable by increased RGC-pJun expression and increased RGC loss.
Specific aim 2. Confirm that rat ONLR-NPC ‘exosomes’ protect RGCs in culture and in vivo during
ischemic ON stress. We will isolate rat ONLR-NPC secreted vesicles and confirm their ability to enhance
RGC survival, by: A) Administering rat ONLR-NPC vesicles and their dissociated components to cultured rat
RGCs, we will quantify their ability to enhance RGC survival and neuritigenesis. I predict improved RGC
survival and increased neuritigenesis. B) Using the rNAION model, we will intravitreally inject rat ONLR-NPC
derived exosomes and their components and determine whether these vesicles improve RGC survival and
reduce stress-related markers such as CRF and pJun. I predict reduced stress levels and improved long-term
RGC survival. Our innovative approach will identify the factors that contribute to RGC stress resistance and
generate new, improved approaches to treatment of optic nerve diseases.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The role of optic nerve lamina region stem cells in age-related optic nerve disease
-
批准号:10707014
-
项目类别:
-
资助金额:$42.73万
-
财政年份:2022
-
负责人:STEVEN L BERNSTEIN
-
依托单位:
Preclinical Analysis of Ischemic Optic Nerve Treatment
-
批准号:9367979
-
项目类别:
-
资助金额:$34.95万
-
财政年份:2017
-
负责人:STEVEN L BERNSTEIN
-
依托单位:
Preclinical analysis of ischemic optic nerve treatment
-
批准号:7908779
-
项目类别:
-
资助金额:$49.28万
-
财政年份:2009
-
负责人:STEVEN L BERNSTEIN
-
依托单位:
Preclinical analysis of ischemic optic nerve treatment
-
批准号:8531941
-
项目类别:
-
资助金额:$23.23万
-
财政年份:2009
-
负责人:STEVEN L BERNSTEIN
-
依托单位:
Preclinical analysis of ischemic optic nerve treatment
-
批准号:8138465
-
项目类别:
-
资助金额:$47.31万
-
财政年份:2009
-
负责人:STEVEN L BERNSTEIN
-
依托单位:
Preclinical analysis of ischemic optic nerve treatment
-
批准号:8328685
-
项目类别:
-
资助金额:$46.7万
-
财政年份:2009
-
负责人:STEVEN L BERNSTEIN
-
依托单位:
Preclinical analysis of ischemic optic nerve treatment
-
批准号:7636201
-
项目类别:
-
资助金额:$54.13万
-
财政年份:2009
-
负责人:STEVEN L BERNSTEIN
-
依托单位:
Mechanisms of Optic Nerve Stroke Neuroprotection
-
批准号:8901174
-
项目类别:
-
资助金额:$37.61万
-
财政年份:2004
-
负责人:STEVEN L BERNSTEIN
-
依托单位:
A functional approach to treating optic nerve stroke
-
批准号:7077651
-
项目类别:
-
资助金额:$32.63万
-
财政年份:2004
-
负责人:STEVEN L BERNSTEIN
-
依托单位:
Mechanisms of Optic Nerve Stroke Neuroprotection
-
批准号:8762089
-
项目类别:
-
资助金额:$38.38万
-
财政年份:2004
-
负责人:STEVEN L BERNSTEIN
-
依托单位:
Mechanisms of optic nerve stroke neuroprotection
-
批准号:7675987
-
项目类别:
-
资助金额:$37.5万
-
财政年份:2004
-
负责人:STEVEN L BERNSTEIN
-
依托单位:
Mechanisms of optic nerve stroke neuroprotection
-
批准号:7915432
-
项目类别:
-
资助金额:$37.13万
-
财政年份:2004
-
负责人:STEVEN L BERNSTEIN
-
依托单位:
Mechanisms of Optic Nerve Stroke Neuroprotection
-
批准号:9334599
-
项目类别:
-
资助金额:$38.38万
-
财政年份:2004
-
负责人:STEVEN L BERNSTEIN
-
依托单位:
Mechanisms of optic nerve stroke neuroprotection
-
批准号:8306934
-
项目类别:
-
资助金额:$35.64万
-
财政年份:2004
-
负责人:STEVEN L BERNSTEIN
-
依托单位:
A functional approach to treating optic nerve stroke
-
批准号:6929927
-
项目类别:
-
资助金额:$33.41万
-
财政年份:2004
-
负责人:STEVEN L BERNSTEIN
-
依托单位:
A functional approach to treating optic nerve stroke
-
批准号:6720179
-
项目类别:
-
资助金额:$33.41万
-
财政年份:2004
-
负责人:STEVEN L BERNSTEIN
-
依托单位:
Mechanisms of optic nerve stroke neuroprotection
-
批准号:7528671
-
项目类别:
-
资助金额:$37.5万
-
财政年份:2004
-
负责人:STEVEN L BERNSTEIN
-
依托单位:
Mechanisms of optic nerve stroke neuroprotection
-
批准号:8138466
-
项目类别:
-
资助金额:$35.64万
-
财政年份:2004
-
负责人:STEVEN L BERNSTEIN
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: